NIH-funded research NIH-funded research

Kinase signaling in brain development and autism at Duke

Official title: Duke Conte Center for Basic Neuroscience on Kinase Signaling in Neurodevelopmental Disorders

Funded at Duke University · NIH-11348636 · Data updated 2026-11-12

A Duke-led center is exploring how protein kinase signaling affects brain development and its link to autism and related disorders.

More Neurodevelopmental Disorders research and trials

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDuke University
NIH-funded
Lab location1 site (Durham, United States)
Project startSeptember 15, 2026
Project endJuly 31, 2031
Funding year2026
Award (this year)$3,068,480
NIH project number1P50MH144133-01
Project IDNIH-11348636 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates include individuals with autism spectrum disorder or related neurodevelopmental conditions, particularly those with variations in kinase signaling pathways.

Less likely to help

People without neurodevelopmental disorders or those whose condition is not linked to kinase signaling may see no direct benefit.

What this research studies

This research center focuses on how kinase signaling affects the timing of brain circuit formation, especially in cells like radial glia, astrocytes, and neurons. Using advanced techniques such as proximity proteomics and single-cell multi-omics, the team aims to identify kinase-driven pathways that, when disrupted, may contribute to autism and other neurodevelopmental conditions. The project is organized into three main research projects with shared computational, engineering, and genomic cores to integrate data and translate findings toward therapeutic ideas.

Why it matters

Potential benefit: If successful, the work could reveal new molecular targets to develop treatments that support healthier brain development in people with autism and related disorders.

How similar studies have gone: Previous work has linked kinase signaling to neurodevelopmental outcomes, with early-stage findings encouraging further exploration of targeted therapies.

Where this research is happening

  • Duke University
    Durham, United States
    Active

Researchers

  • Principal investigator: Soderling, Scott H — Duke University
  • Study coordinator: Soderling, Scott H

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.